A production line of Wegovy injection pens at a Novo Nordisk A/S pharmaceutical manufacturing facility. - Yahoo

President Donald Trump’s plan to impose a 100% tariff on branded and patented drug imports was greeted with a shrug by many investors, who are betting his exemptions for companies with US manufacturing will soften any blow.